secwatch.observer — SEC 8-K summary
======================================

Issuer:     Progyny, Inc. (PGNY)
CIK:        0001551306
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001551306-26-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Progyny Q4 revenue up 6.7% to $318.4M; guides FY2026 revenue $1.355B-$1.405B
----------------------------------------------------------------------------

- Q4 revenue $318.4M (+6.7% YoY); FY2025 revenue $1.2887B (+10% YoY); gross margin expanded to 24.1%.
- Q4 net income $12.5M ($0.14 diluted EPS); adj. EPS $0.48; adj. EBITDA $51.4M (16.1% margin).
- Full year operating cash flow record $210.2M; repurchased 3.3M shares in Q4, 6.5M total under $200M authorization.
- FY2026 revenue guidance $1.355B-$1.405B; adj. EBITDA $224M-$239M; adj. EPS $1.83-$1.95.
- Client count 555 as of Dec 2025 (up from 473); expects ~600 clients representing ~7.2M covered lives in 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551306/000155130626000012/0001551306-26-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551306/000155130626000012/pgny-20260226.htm
  HTML page:      https://secwatch.observer/filing/0001551306-26-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer